Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
J Pediatr 159:10041011
Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6
In case there is any post-treatment discomfort, consulting the provider is advised
C.IngoldI.et al (2019)
Stareini, P
US$ 24.63
US$ 27.45
US$ 20.47
US$ 21.01
US$ 27.76
US$ 29.27
US$ 23.07
US$ 29.08
US$ 20.58
